Design and expression of chimeric U1/ribozyme transgenes
- PMID: 15017051
- DOI: 10.1385/1-59259-746-7:209
Design and expression of chimeric U1/ribozyme transgenes
Abstract
The U1snRNA/ribozyme/antisense construct (designated U1/ribozyme) is a chimeric transgene that has proven to be very useful for inhibiting the expression of targeted genes in vitro and in vivo. It consists of a combination of hammerhead ribozyme flanked by target-specific antisense sequences that are in turn flanked by the loops and promoter of U1 snRNA. To construct U1/ribozymes, antisense/ribozyme sequences are first designed corresponding to ribozyme-cleavage consensus "GUC" sequences that are present in the targeted mRNA. Antisense/ribozyme sequences are then inserted between the U1 snRNA loops, and the conceptual secondary structure of the encoded regulatory RNA is analyzed to ensure proper folding. Appropriate antisense/ribozymes are then synthesized as oligonucleotides, annealed, and ligated into the pU1 vector containing the U1 snRNA promoter and loops to yield the pU1/ribozyme expression vector. Constructs can then be transiently or stably expressed in vitro and in vivo to inhibit the expression of target genes. U1/ribozymes can also be expressed in viral vectors for more efficient transfection, or complexed to liposomes for systemic delivery.
Similar articles
-
[Inhibition of HCV replication by HCV specific U1 small nuclear RNA chimeric ribozyme in vivo].Zhonghua Gan Zang Bing Za Zhi. 2006 Jan;14(1):11-4. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16420757 Chinese.
-
[Study on the cleavage activity of U1 small nuclear RNA chimeric ribozyme against HCV RNA in vitro].Zhonghua Gan Zang Bing Za Zhi. 2004 Dec;12(12):749-51. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15619345 Chinese.
-
Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.Biochemistry. 1994 Oct 11;33(40):12127-38. doi: 10.1021/bi00206a016. Biochemistry. 1994. PMID: 7918434
-
Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.Antisense Res Dev. 1991 Fall;1(3):285-8. Antisense Res Dev. 1991. PMID: 1821650 Review.
-
Hammerhead ribozymes: biochemical and chemical considerations.Curr Opin Mol Ther. 2000 Jun;2(3):272-81. Curr Opin Mol Ther. 2000. PMID: 11249621 Review.
Cited by
-
Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme.Genome Biol. 2023 Jan 17;24(1):9. doi: 10.1186/s13059-023-02852-w. Genome Biol. 2023. PMID: 36650600 Free PMC article.
-
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.Neuro Oncol. 2005 Oct;7(4):436-51. doi: 10.1215/S1152851705000050. Neuro Oncol. 2005. PMID: 16212809 Free PMC article. Review.
-
Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition.Clin Cancer Res. 2013 Mar 15;19(6):1433-44. doi: 10.1158/1078-0432.CCR-12-2832. Epub 2013 Feb 5. Clin Cancer Res. 2013. PMID: 23386689 Free PMC article.
-
Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro.World J Surg Oncol. 2012 Jun 28;10:128. doi: 10.1186/1477-7819-10-128. World J Surg Oncol. 2012. PMID: 22741575 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources